MATTHEW SHUTE: Open Payments
NPI 1639198526 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,357 in 80 payments from 24 companies in 2025. Trend: 2023 $1,043 · 2024 $1,308 · 2025 $1,357
Food & beverage: $1,357
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $148 |
| ABBVIE INC. | 11 | $140 |
| Lilly USA, LLC | 6 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $107 |
| Otsuka America Pharmaceutical, Inc. | 6 | $106 |
| GlaxoSmithKline, LLC. | 5 | $94 |
| Astellas Pharma US Inc | 4 | $73 |
| Exact Sciences Corporation | 3 | $67 |
| Novo Nordisk Inc | 4 | $61 |
| Phathom Pharmaceuticals, Inc. | 6 | $57 |
Products named: CAPLYTA, REXULTI, MOUNJARO, NURTEC ODT, TRELEGY ELLIPTA, UBRELVY, Veozah, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
